Implementation of the 9th TNM for lung cancer: practical insights for radiologists
- Gianluca Argentieri 1, Clara Valsecchi 1, Francesco Petrella 2, Lisa Jungblut 3, Thomas Frauenfelder 3, Filippo Del Grande 1,4, Stefania Rizzo 5,6
- 1Clinic of Radiology, Imaging Institute of Southern Switzerland (IIMSI), Ente Ospedaliero Cantonale (EOC), Via Tesserete 46, 6900, Lugano, Switzerland.
- 2Department of Thoracic Surgery, Fondazione IRCCS San Gerardo dei Tintori, 20900, Monza, Italy.
- 3Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.
- 4Faculty of Biomedical Sciences, Università Della Svizzera Italiana (USI), Via G. Buffi 13, 6904, Lugano, Switzerland.
- 5Clinic of Radiology, Imaging Institute of Southern Switzerland (IIMSI), Ente Ospedaliero Cantonale (EOC), Via Tesserete 46, 6900, Lugano, Switzerland. stefania.rizzo@eoc.ch.
- 6Faculty of Biomedical Sciences, Università Della Svizzera Italiana (USI), Via G. Buffi 13, 6904, Lugano, Switzerland. stefania.rizzo@eoc.ch.
- 0Clinic of Radiology, Imaging Institute of Southern Switzerland (IIMSI), Ente Ospedaliero Cantonale (EOC), Via Tesserete 46, 6900, Lugano, Switzerland.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The 9th edition of the tumor node metastasis (TNM) lung cancer classification system updates N2 and M1c categories. These changes improve prognostic accuracy and may expand treatment options for lung cancer patients.
Area Of Science
- Oncology
- Radiology
- Cancer Staging
Background
- Lung cancer remains a leading cause of cancer-related mortality globally.
- The tumor node metastasis (TNM) classification system is essential for staging lung cancer.
- Previous TNM editions lacked granularity in certain categories, impacting treatment decisions.
Purpose Of The Study
- To detail the significant updates in the 9th edition of the TNM classification system for lung cancer.
- To highlight the revised N2 and M1c categories and their prognostic implications.
- To emphasize the role of enhanced imaging in the accurate application of the new TNM staging.
Main Methods
- Review of the 9th edition TNM classification criteria for lung cancer.
- Analysis of the newly introduced subcategories for N2 (N2a, N2b) and M1c (M1c1, M1c2) descriptors.
- Discussion of the impact of these changes on anatomical staging and potential treatment implications.
Main Results
- The N2 category is now divided into N2a (single-station) and N2b (multiple-station) involvement.
- The M1c category is subcategorized into M1c1 (single organ system metastases) and M1c2 (multiple organ system metastases).
- These revisions allow for more precise staging, potentially leading to downstaging and expanded therapeutic options.
Conclusions
- The 9th TNM classification offers improved prognostic stratification for lung cancer.
- Accurate radiological interpretation is critical for applying the updated staging system.
- Adoption of the 9th TNM by radiologists facilitates clearer communication and better patient care decisions.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

